| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30008124 | HIV | ENSG00000128271.22 | protein_coding | ADORA2A | No | No | 135 | P29274 X5DNB4 |
| TVIS44031350 | HTLV-1 | ENSG00000128271.22 | protein_coding | ADORA2A | No | No | 135 | P29274 X5DNB4 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | ADORA2A |
|---|---|
| DrugBank ID | DB00277 |
| Drug Name | Theophylline |
| Target ID | BE0000924 |
| UniProt ID | P29274 |
| Regulation Type | antagonist |
| PubMed IDs | 16357952; 3588607 |
| Citations | Pechlivanova DM, Georgiev VP: Effects of single and long-term theophylline treatment on the threshold of mechanical nociception: contribution of adenosine A1 and alpha2-adrenoceptors. Methods Find Exp Clin Pharmacol. 2005 Nov;27(9):659-64.@@Daly JW, Jacobson KA, Ukena D: Adenosine receptors: development of selective agonists and antagonists. Prog Clin Biol Res. 1987;230:41-63. |
| Groups | Approved |
| Direct Classification | Xanthines |
| SMILES | CN1C2=C(NC=N2)C(=O)N(C)C1=O |
| Pathways | Caffeine Metabolism |
| PharmGKB | PA451647 |
| ChEMBL | CHEMBL190 |
